欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号IS/H/0587/001
药品名称Sclarint 0,44 mg/ml stungulyf, lausn
活性成分
    • Eribulin mesilate 0.44 mg/ml
剂型Solution for injection
上市许可持有人Adalvo Limited Malta Life Sciences Park Building 1 Level 4 Sir Temi Zammit Buildings San Gwann Industrial Estate SGN 3000 San Gwann Malta
参考成员国 - 产品名称Iceland (IS)
Sclarint 0,44 mg/ml stungulyf, lausn
互认成员国 - 产品名称
    • Bulgaria (BG)
许可日期2023/06/06
最近更新日期2023/10/31
药物ATC编码
    • L01XX41 eribulin
申请类型
  • TypeLevel1:Known Active Substance
  • TypeLevel2:Initial Application
  • TypeLevel3:Generic Art 10.1 and 10.2 Dir 2001/83/EC
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Prescription Only
附件文件下载
市场状态Positive
©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase